[Lecture Report] The Pharmaceutical Manufacturers Association of Japan Media Forum – “Preparing for Antimicrobial Resistance (AMR) Awareness Month” (November 8, 2022)
date : 11/28/2022
Tags: AMR
Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno gave a lecture titled, “Efforts of AMR Alliance Japan” at the Pharmaceutical Manufacturers Association of Japan’s Media Forum titled, “Preparing for Antimicrobial Resistance (AMR) Awareness Month.” The forum was organized by the International Committee of the Japan Pharmaceutical Manufacturers Association (JPMA) in cooperation with AMR Alliance Japan. The lecture focused on the efforts of AMR Alliance Japan undertaken for seven main themes and discussed the importance of awareness-raising activities and public collaboration.
Speakers (Titles omitted, in order of presentation)
Akiko Honda (Parliamentary Vice-Minister, Health, Labour and Welfare)
Tomohiro Onishi (Deputy Director-General, Office for COVID-19 and Other Emerging Infectious Disease Control, Cabinet Secretariat)
Kazuhiro Tateda (Committee Chairman, Joint Review Committee of the Seven Academic Societies for the Promotion of Infectious Disease Therapy and Drug Discovery; Professor, Department of Microbiology and Infectious Diseases, Toho University)
Yui Kohno (Manager, Health and Global Policy Institute)
Yusuke Ariyoshi (Leader, Infectious Disease Group Chair, Global Health Subcommittee International Affairs Committee, Japan Pharmaceutical Manufacturers Association)
AMR Alliance Japan is an independent platform for multi-stakeholder discussions on AMR measures that was established in November 2018. Since its establishment, AMR Alliance Japan has worked with Alliance members and partner organizations to deepen the policy debate around AMR. One result of these activities was the presentation of “AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting AMR Countermeasures” in July 2019. Moving forward, the Alliance will take every opportunity to explain these recommendations to AMR policy stakeholders and take steps toward concrete policy action on AMR.
AMR Alliance Japan was established in November 2018 as a multi-stakeholder, collaborative organization dedicated to the improvement of public health through the promotion of AMR countermeasures. As of November 2022, its members include MSD K.K., The Children and Healthcare Project, Shionogi & Co., Ltd., Sumitomo Pharma Co., Ltd., The Japanese Society of Antimicrobials for Animals, NISSUI Pharmaceutical Co., Ltd., Nippon Becton Dickinson Co., Ltd., The Japan Medical Association, The Japanese Society for Medical Mycology, The Japanese Society of Pharmaceutical Health Care and Sciences, The Japanese Society of Chemotherapy, The Japanese Society for Infection Prevention and Control, The Japanese Association for Infectious Diseases, The Japanese Society for Pediatric Infectious Diseases, The Japan Pharmaceutical Manufacturers Association, The Japanese Society of Therapeutic Drug Monitoring, The Japan Society of Hospital Pharmacists, The Pharmaceutical Society of Japan, The Japan Pharmaceutical Association, The Japanese Society for Clinical Microbiology, bioMérieux Japan Ltd., Himeji City, Pfizer Japan Inc., and Meiji Seika Pharma Co., Ltd. Health and Global Policy Institute (HGPI) serves as its secretariat.
【Seven Policy Recommendations by AMR Alliance Japan】
1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities.
2. Constructing domestic AMR surveillance and crisis management systems.
3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology.
4. Supporting education on AMR for the public and medical practitioners.
5. Establishing incentive models to encourage R&D for antimicrobials.
6. Stabilizing the supply of antimicrobials.
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad.
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
Featured Posts
-
2024-04-12
[Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
-
2024-04-16
[Activity Report] HGPI Child Health Project Selected to Implement FY2024 Nippon Foundation Grant Program, “Establishing a Skill Development Program and Collaborative Network for Improving Mental Health for Students with Intellectual Disabilities” (April 15, 2024)
-
2024-04-18
[Event Report] NCDs-related Cross-project Meeting: The 2nd Meeting on Non-Communicable Disease in Hokkaido and Tohoku (March 15, 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)